OnCo

RUNX1T1 (RUNX1 partner transcriptional co-repressor 1) is a protein that switches other genes on and off. The public catalogues list it as an oncogene driver, a tumour suppressor and a fusion partner, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Lung cancer, Leukaemia, Hepatocellular carcinoma and 5 more. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.

Biology

Transcriptional corepressor which facilitates transcriptional repression via its association with DNA-binding transcription factors and recruitment of other corepressors and histone-modifying enzymes. Can repress the expression of MMP7 in a ZBTB33-dependent manner. Can repress transactivation mediated by TCF12. Acts as a negative regulator of adipogenesis. The AML1-MTG8/ETO fusion protein frequently found in leukaemic cells is involved in leukemogenesis and contributes to haematopoietic stem/progenitor cell self-renewal. Location: Nucleus (UniProt). Locus 8q21.3 (HGNC).

Where it is found
  • Lung cancer: Open Targets association 0.58 with lung cancer (MONDO_0008903)
  • Leukaemia: Open Targets association 0.57 with leukaemia (MONDO_0005059)
  • Hepatocellular carcinoma: IntOGen driver in 1 cohort (HCC)
  • Prostate cancer: IntOGen driver in 1 cohort (PRAD)
  • Skin cancer: Open Targets association 0.55 with skin cancer (MONDO_0002898)
  • Breast cancer: Open Targets association 0.54 with breast cancer (MONDO_0007254)
Class: transcription · Gene: RUNX1T1 · Facts checked 2026-09-23 · Target page

External identifiers

Built from HGNC, Ensembl, UniProt and ChEMBL ids

Products by modality and phase

Browse products →

No product in the corpus is aimed at this target yet.

No trial in the corpus names this target or one of its products.

Resistance routes

Unaddressed routes →

The resistance atlas has no route that names this target.

No pathway diagram carries this target as a node.

Companion diagnostics

Assay registry →

No companion diagnostic in the registry measures this target.

Preclinical models

All models →

No model entry for this target yet; check the cancer entries on the models page.

No open questions recorded for this target yet. Suggest one.

Literature

Preprints →
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this target: (TITLE:"RUNX1T1" OR ABSTRACT:"RUNX1T1" OR TITLE:"RUNX1 partner transcriptional co-repressor 1" OR ABSTRACT:"RUNX1 partner transcriptional co-repressor 1" OR TITLE:"MTG8" OR ABSTRACT:"MTG8" OR TITLE:"ZMYND2" OR ABSTRACT:"ZMYND2" OR TITLE:"AML1T1" OR ABSTRACT:"AML1T1" OR TITLE:"CBFA2T1" OR ABSTRACT:"CBFA2T1") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about RUNX1T1, not a curated reading list.

Export

The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/runx1t1.json. Licence CC BY-NC 4.0.